| Should all papillary thyroid microcarcinomas be aggressively treated?: an analysis of 18,445 cases XM Yu, Y Wan, RS Sippel, H Chen Annals of surgery 254 (4), 653-660, 2011 | 365 | 2011 |
| Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases XM Yu, CY Lo, WF Chan, KY Lam, P Leung, JM Luk Clinical Cancer Research 11 (22), 8063-8069, 2005 | 172 | 2005 |
| Follicular variant of papillary thyroid carcinoma is a unique clinical entity: a population-based study of 10,740 cases XM Yu, DF Schneider, G Leverson, H Chen, RS Sippel Thyroid 23 (10), 1263-1268, 2013 | 158 | 2013 |
| Chrysin activates Notch1 signaling and suppresses tumor growth of anaplastic thyroid carcinoma in vitro and in vivo XM Yu, TA Phan, PN Patel, R Jaskula‐Sztul, H Chen Cancer 119 (4), 774-781, 2013 | 113 | 2013 |
| Serum vascular endothelial growth factor C correlates with lymph node metastases and high-risk tumor profiles in papillary thyroid carcinoma XM Yu, CY Lo, AKY Lam, P Leung, JM Luk Annals of surgery 247 (3), 483-489, 2008 | 111 | 2008 |
| Resveratrol induces differentiation markers expression in anaplastic thyroid carcinoma via activation of Notch1 signaling and suppresses cell growth XM Yu, R Jaskula-Sztul, K Ahmed, AD Harrison, M Kunnimalaiyaan, ... Molecular cancer therapeutics 12 (7), 1276-1287, 2013 | 109 | 2013 |
| Notch1‐Snail1‐E‐cadherin pathway in metastatic hepatocellular carcinoma XQ Wang, W Zhang, ELH Lui, Y Zhu, P Lu, X Yu, J Sun, S Yang, ... International Journal of Cancer, 2012 | 109 | 2012 |
| The roles of the epithelial-mesenchymal transition marker PRRX1 and miR-146b-5p in papillary thyroid carcinoma progression H Hardin, Z Guo, W Shan, C Montemayor-Garcia, S Asioli, XM Yu, ... The American journal of pathology 184 (8), 2342-2354, 2014 | 101 | 2014 |
| Hesperetin activates the Notch1 signaling cascade, causes apoptosis, and induces cellular differentiation in anaplastic thyroid cancer PN Patel, XM Yu, R Jaskula-Sztul, H Chen Annals of surgical oncology 21, 497-504, 2014 | 69 | 2014 |
| Novel approaches in anaplastic thyroid cancer therapy KT Hsu, XM Yu, AW Audhya, JC Jaume, RV Lloyd, S Miyamoto, TA Prolla, ... The oncologist 19 (11), 1148-1155, 2014 | 63 | 2014 |
| Antiproliferative effect of chrysin on anaplastic thyroid cancer TA Phan, XM Yu, M Kunnimalaiyaan, H Chen Journal of Surgical Research 170 (1), 84-88, 2011 | 61 | 2011 |
| Notch in the development of thyroid C-cells and the treatment of medullary thyroid cancer M Cook, XM Yu, H Chen American journal of translational research 2 (1), 119, 2010 | 61 | 2010 |
| The potential clinical relevance of serum vascular endothelial growth factor (VEGF) and VEGF-C in recurrent papillary thyroid carcinoma XM Yu, CY Lo, AKY Lam, BHH Lang, P Leung, JM Luk Surgery-St Louis 144 (6), 934, 2008 | 57 | 2008 |
| Tumor-suppressor role of Notch3 in medullary thyroid carcinoma revealed by genetic and pharmacological induction R Jaskula-Sztul, J Eide, S Tesfazghi, A Dammalapati, AD Harrison, XM Yu, ... Molecular cancer therapeutics 14 (2), 499-512, 2015 | 46 | 2015 |
| Notch1 signaling regulates the aggressiveness of differentiated thyroid cancer and inhibits SERPINE1 expression XM Yu, R Jaskula-Sztul, MR Georgen, Z Aburjania, YR Somnay, ... Clinical Cancer Research 22 (14), 3582-3592, 2016 | 45 | 2016 |
| Current treatment of papillary thyroid microcarcinoma. XM Yu, R Lloyd, H Chen Advances in surgery 46, 191, 2012 | 36 | 2012 |
| Generation of novel thyroid cancer stem-like cell clones: effects of resveratrol and valproic acid H Hardin, XM Yu, AD Harrison, C Larrain, R Zhang, J Chen, H Chen, ... The American Journal of Pathology 186 (6), 1662-1673, 2016 | 32 | 2016 |
| Notch3 expression correlates with thyroid cancer differentiation, induces apoptosis, and predicts disease prognosis YR Somnay, XM Yu, RV Lloyd, G Leverson, Z Aburjania, S Jang, ... Cancer 123 (5), 769-782, 2017 | 31 | 2017 |
| The novel histone deacetylase inhibitor thailandepsin A inhibits anaplastic thyroid cancer growth E Weinlander, Y Somnay, AD Harrison, C Wang, YQ Cheng, ... journal of surgical research 190 (1), 191-197, 2014 | 27 | 2014 |
| Novel analogs targeting histone deacetylase suppress aggressive thyroid cancer cell growth and induce re-differentiation S Jang, XM Yu, S Odorico, M Clark, R Jaskula-Sztul, CM Schienebeck, ... Cancer Gene Therapy 22 (8), 410-416, 2015 | 24 | 2015 |
